Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06362161 · ClinicalTrials.gov registry record
Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
A clinical trial of Convulsion, Non-Epileptic and Functional Neurological Disorder, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- 1,100
- Enrollment target
- 1
- Study location
NCT06362161: Recruiting study of Convulsion, Non-Epileptic and Functional Neurological Disorder, sponsored by University of Alabama at Birmingham.
NCT06362161 is a study of Convulsion, Non-Epileptic and Functional Neurological Disorder that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 1,100 participants, above the 97-participant average among 4 other Convulsion, Non-Epileptic trials with a reported enrollment target (1034% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06362161, a study of Convulsion, Non-Epileptic and Functional Neurological Disorder, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- 1,100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to help providers develop an interdisciplinary treatment pathway for functional neurological disorder (FND) at University of Alabama at Birmingham (UAB), and will involve psychiatry, speech therapy, physical therapy, and occupational therapy. The study will also help providers to evaluate the treatment pathway and publish results regarding the process and outcomes.
Primary Outcome
Includes questions regarding patient's demographic information, referring physician, current symptoms, medical history, and recent functioning including work and school missed, mobility aids used, or receipt of disability service. Completed by adult FND patients and parent/guardian of pediatric FND patients during the intake therapy session before beginning treatment and after completing FND treatment.
Conditions Studied
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2025-07-18 |
| Est. Completion | 2028-12-31 |
What NCT06362161 shows while recruiting
NCT06362161 is an observational study that tracks outcomes without assigning an intervention. Its 1,100 participants enrollment target places it among the larger protocols in the corpus, above the 97-participant average among 4 other Convulsion, Non-Epileptic trials with a reported enrollment target (1034% higher).
The record links to 3 conditions, with Convulsion, Non-Epileptic appearing as the primary indexed condition, and to 0 interventions.
NCT06362161 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06362161 about?
NCT06362161 is a clinical study titled "Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND". The purpose of this study is to help providers develop an interdisciplinary treatment pathway for functional neurological disorder (FND) at University of Alabama at Birmingham (UAB), and will involve psychiatry, speech therapy, physical therapy, and occupational therapy. The study will also help pro...
What is the current status of trial NCT06362161?
This trial is currently recruiting. The enrollment target is 1,100 participants. The study started on 2025-07-18. Estimated completion is 2028-12-31.
What conditions does trial NCT06362161 study?
This clinical trial studies the following conditions: Convulsion, Non-Epileptic, Functional Neurological Disorder, Functional Seizure.
Who is sponsoring clinical trial NCT06362161?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06362161 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Convulsion, Non-Epileptic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Retraining and Control Therapy (ReACT) R33 Phase
RECRUITING · NA
-
Retraining and Control Therapy (ReACT)- Adults
RECRUITING · NA
-
Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
RECRUITING · NA
-
A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI